Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Osamu Morimura"'
Autor:
Kengo Matsumoto, Tsutomu Nishida, Dai Nakamatsu, Masashi Yamamoto, Koji Fukui, Osamu Morimura, Kinya Abe, Yukiyoshi Okauchi, Hiromi Iwahashi, Masami Inada
Publikováno v:
Clinics and Practice, Vol 14, Iss 4, Pp 1601-1614 (2024)
Background: The prognostic significance of liver dysfunction in COVID-19 patients remains unclear. In this study, we investigated the association between liver function test results and severe disease progression in COVID-19 patients. Methods: This r
Externí odkaz:
https://doaj.org/article/3fb348d659824a5d97c00d6170a917ec
Autor:
Yuhei Kinehara, MD, PhD, Takayuki Shiroyama, MD, PhD, Akihiro Tamiya, MD, Motohiro Tamiya, MD, Seigo Minami, MD, PhD, Masaki Kanazu, MD, Osamu Morimura, MD, PhD, Toshie Niki, MD, PhD, Satoshi Tetsumoto, MD, PhD, Yoshihiko Taniguchi, MD, Tomoki Kuge, MD, Kazumi Nishino, MD, PhD, Izumi Nagatomo, MD, PhD, Atsushi Kumanogoh, MD, PhD, Isao Tachibana, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 11, Pp 100586- (2023)
Introduction: Durvalumab consolidation therapy is the standard of care after concurrent chemoradiotherapy (CRT) for stage III NSCLC. Immune-related pneumonitis during durvalumab treatment is potentially fatal; however, information is lacking regardin
Externí odkaz:
https://doaj.org/article/c22883f5a74346ae94c511208d4a9489
Autor:
Tomoki Kuge, MD, Takayuki Shiroyama, MD, PhD, Akihiro Tamiya, MD, Motohiro Tamiya, MD, Masaki Kanazu, MD, Yuhei Kinehara, MD, PhD, Tsunehiro Tanaka, MD, Osamu Morimura, MD, PhD, Yoshihiko Taniguchi, MD, Toshie Niki, MD, PhD, Satoshi Tetsumoto, MD, PhD, Kazuhiko Hayashi, MD, PhD, Kazumi Nishino, MD, PhD, Izumi Nagatomo, MD, PhD, Atsushi Kumanogoh, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 5, Pp 100505- (2023)
Introduction: Durvalumab maintenance therapy after definitive concurrent chemoradiotherapy (CRT) is the standard treatment modality for stage III NSCLC. Although severe treatment-related lymphopenia (TRL) during CRT may impair the efficacy of subsequ
Externí odkaz:
https://doaj.org/article/dc6115d79b3b49f897868ff430d9099c
Autor:
Yingji Jin, Yoshito Takeda, Yasushi Kondo, Lokesh P. Tripathi, Sujin Kang, Hikari Takeshita, Hanako Kuhara, Yohei Maeda, Masayoshi Higashiguchi, Kotaro Miyake, Osamu Morimura, Taro Koba, Yoshitomo Hayama, Shohei Koyama, Kaori Nakanishi, Takeo Iwasaki, Satoshi Tetsumoto, Kazuyuki Tsujino, Muneyoshi Kuroyama, Kota Iwahori, Haruhiko Hirata, Takayuki Takimoto, Mayumi Suzuki, Izumi Nagatomo, Ken Sugimoto, Yuta Fujii, Hiroshi Kida, Kenji Mizuguchi, Mari Ito, Takashi Kijima, Hiromi Rakugi, Eisuke Mekada, Isao Tachibana, Atsushi Kumanogoh
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Abstract Chronic obstructive pulmonary disease (COPD) has been recently characterized as a disease of accelerated lung aging, but the mechanism remains unclear. Tetraspanins have emerged as key players in malignancy and inflammatory diseases. Here, w
Externí odkaz:
https://doaj.org/article/da2c46c81ad548f99dba428cdb8e98c6
Autor:
Shinji Kuriki, Tsutomu Nishida, Li-sa Chang, Kana Hosokawa, Yoshifumi Fujii, Naoto Osugi, Dai Nakamatsu, Kengo Matsumoto, Masashi Yamamoto, Osamu Morimura, Kinya Abe, Yukiyoshi Okauchi, Hiromi Iwahashi, Masami Inada
GI symptoms are common in acute COVID-19 patients. This study aimed to characterize the GI symptoms occurring in Japanese COVID-19 patients. This retrospective single-center cohort study included 751 hospitalized acute COVID-19 patients. The primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1908ce42645c89330323fcf4cacb90a1
Autor:
Kinya Abe, Koichi Sawada, Yukiyoshi Okauchi, Yasushi Otani, Hiromi Iwahashi, Kanae Matsuno, Masaru Yokoe, Naohiko Ito, Tsutomu Nishida, Osamu Morimura, Akiko Kawasaki
Publikováno v:
Endocrine Journal. 68:849-856
At the current time of rising demand for hospital beds, it is important to triage COVID-19 patients according to the treatment needed during hospitalization. The need for oxygen therapy is an important factor determining hospital admission of these p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fad52edd4ad04237480b8eaf6894da8
https://doi.org/10.1507/endocrj.ej20-0784
https://doi.org/10.1507/endocrj.ej20-0784
Autor:
Masakazu Tamai, Rika Sakamoto, Noriko Goto, Osamu Morimura, Tsutomu Nishida, Hiromi Iwahashi, Akinori Yokomi
Publikováno v:
The Journal of dermatology. 49(9)
Some patients with coronavirus disease 2019 (COVID-19) develop skin manifestations. There may be regional and racial differences in the frequency and type of COVID-19-associated skin manifestations. There are, however, few reports on skin manifestati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c12d5e148a8fe9b7f13c50c2068c40b
https://pubmed.ncbi.nlm.nih.gov/35535659
https://pubmed.ncbi.nlm.nih.gov/35535659
Autor:
Dai Nakamatsu, Osamu Morimura, Kaori Mukai, Yoshifumi Fujii, Naoto Osugi, Aya Sugimoto, Tsutomu Nishida, Shiro Adachi, Masashi Yamamoto, Kengo Matsumoto, Kazumasa Soma
Publikováno v:
Clinical journal of gastroenterology. 15(1)
A 56-year-old man with advanced lung adenocarcinoma presented to the emergency department with a 6-day history of diarrhea. He was treated for lung cancer with nivolumab 3 mg/kg (144 mg/body) every 2 weeks (Q2W), followed by an increase to 240 mg Q2W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::230093a8232f2f89e27137bcf44a3c72
https://pubmed.ncbi.nlm.nih.gov/34716545
https://pubmed.ncbi.nlm.nih.gov/34716545
Autor:
Shingo Kanemura, Maiko Niki, Yasuhiro Nakajima, Takashi Kijima, Osamu Morimura, Hidemi Kitai, Hirotoshi Ishigaki, Eisuke Shibata, Eriko Fujimoto, Ryo Takahashi, Toshiyuki Minami, Koji Mikami, Takashi Yokoi, Yoshiki Negi, Daisuke Horio, Yuichi Koda, Kozo Kuribayashi
Publikováno v:
Biochemical and Biophysical Research Communications. 519:846-853
Small-cell lung cancer (SCLC) is characterized by one of neuroendocrine tumors, and is a clinically aggressive cancer due to its rapid growth, early dissemination, and rapid acquisition of multidrug resistance to chemotherapy. Moreover, the standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8fd5d052934c45d646d11e9241c4e2
https://doi.org/10.1016/j.bbrc.2019.09.076
https://doi.org/10.1016/j.bbrc.2019.09.076
Publikováno v:
Internal Medicine
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis characterized by asthma, eosinophilia, and diffuse eosinophilic infiltration. Although cardiovascular involvement is common and a leading cause of EGPA-related mortali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cfea5936822e9c621470d0e834f9dff
http://europepmc.org/articles/PMC6859378
http://europepmc.org/articles/PMC6859378